viewCoinsilium Group Limited

Coinsilium eyes maturation of blockchain industry


  • Investment and advisory firm
  • Focuses on developing early-stage blockchain companies
  • Also provides advisory services for token generation events
Blockchain technology

Quick facts: Coinsilium Group Limited

Price: 2.45 GBX

Market: AQSE
Market Cap: -

As a company, Coinsilium is exceptionally well positioned with a robust financial model and an ability to leverage shareholder returns at an exciting time in the blockchain industry

Coinsilium CEO Eddy Travia

What Coinsilium does

Coinsilium Group Limited (LON:COIN) is an investment firm that finances and manages the development of early-stage blockchain technology companies.

The company also provides advisory services for firms planning token generation events.

Inflexion points

  • In January, the group unveiled an investment agreement with IOV Labs, the developer of a smart contract platform secured by the Bitcoin network
  • In its half-year results, the company hailed a recovery and “rapid maturation” of the cryptocurrency and blockchain industry as it looked to expand its advisory services arm
  • In November, it signed a memorandum of understanding (MoU) with tech firm Devmons Management with plans to launch a blockchain software and smart contract development studio in Gibraltar
  • Indorse, a company in which Consilium holds a 10% stake, has received a US$6.5mln investment from the Times Group, India’s largest media house
  • In July, Coinsilium landed a new advisory client Jur AG, a new blockchain-based decentralised legal ecosystem, to assist with the company’s fundraising and global development

Interview – chief executive Eddy Travia

How it’s doing

For the six months ended 30 June 2019, Coinsilium reported a profit from continuing operations of £237,787, down from £554,605 in the prior year, while revenues fell to £108,967 from £1.3mln as a result of fees generated from token advisory services.

“Despite less than favourable market conditions for the first half of this period, it was pleasing to see that by the close, a sector-wide recovery was well underway, with the industry also regaining much of its previous momentum”, Palle said.

“Across the company's investing, venture building and advisory services divisions, we look forward to the future with confidence”, he added.

In an update in April, the company said its portfolio companies and partners are “well prepared to face the challenges and respond to the needs of a post-coronavirus world”.

“The disruption caused by the measures taken to fight the coronavirus also show a move towards increased reliance on electronic forms of communication and payments by businesses and individuals. We see this global move as the generator of new opportunities for blockchain companies around the world”, the company said in a statement.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Coinsilium Group Limited named herein, including the promotion by the Company of Coinsilium Group Limited in any Content on the Site, the...



Revive Therapeutics: Analyst sees 'substantial upside potential' as key...

Proactive Research analyst Ed Stacey says Revive Therapeutics (CSE:RVV)(OTCQB:RVVTF) is a speciality life sciences company focussed on repurposing drugs for rare and infectious diseases and has a pipeline of of three main platforms. One of them is Bucillamine (BUC) which is a medication with a...

4 days, 16 hours ago

2 min read